Skip to main content
Signal8

Corzo Kathryn Penkus

SEC insider (Form 3/4/5 filer). CIK 0001884123. Director at Marker Therapeutics, Inc. (MRKR). 1 reported Form 4/5 transaction since Sep 2024; latest on Oct 31, 2025. Located in HOUSTON, TX.

Companies Corzo Kathryn Penkus has filed insider reports for

  • Marker Therapeutics, Inc. (MRKR): Director
Corzo Kathryn Penkus profile photo

Corzo Kathryn Penkus

CIK: 0001884123

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Marker Therapeutics, Inc. logo
MRKR

Marker Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Marker Therapeutics, Inc. logo
    MRKR

    Marker Therapeutics, Inc.

    Oct 31, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    147.6K shares-

1-1 of 1